Zynexの機関の所有権
Zynexの機関の所有権は何ですか。
Zynex, Inc.の機関の所有権は35.76%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
TSXのセクタHealth Careにおける機関の所有権の企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似の機関の所有権
- Calamos Global Total Return Fundの機関の所有権は35.68%です。
- BlackRock MuniYield Quality Fund III Incの機関の所有権は35.69%です。
- Lightpath Technologiesの機関の所有権は35.70%です。
- Macquarieの機関の所有権は35.71%です。
- immatics biotechnologies GmbHの機関の所有権は35.73%です。
- Total SAの機関の所有権は35.75%です。
- Zynexの機関の所有権は35.76%です。
- Carbon Revolutionの機関の所有権は35.78%です。
- Azul S.Aの機関の所有権は35.78%です。
- Chemungの機関の所有権は35.78%です。
- Leifheit AGの機関の所有権は35.79%です。
- Spireの機関の所有権は35.80%です。
- STMicroelectronics N.Vの機関の所有権は35.80%です。